Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2‐VASc Scores: Findings From the ORBIT‐AF I and II Registries
Jackson L, Kim S, Fonarow GC, Freeman JV, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Singer D, Thomas L, Blanco R, Peterson ED, Piccini J, Patients and Investigators T. Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2‐VASc Scores: Findings From the ORBIT‐AF I and II Registries. Journal Of The American Heart Association 2018, 7: e008764. PMID: 30369317, PMCID: PMC6201408, DOI: 10.1161/jaha.118.008764.Peer-Reviewed Original ResearchConceptsOral anticoagulationAtrial fibrillationTreatment strategiesCardiology/American Heart Association guidelinesStroke/transient ischemic attackLow CHA2DS2-VASc scoreAmerican Heart Association guidelinesCHA2DS2-VASc scoreThromboembolic event rateTransient ischemic attackHeart Association guidelinesCurrent American CollegePatterns of treatmentIschemic attackVASc scoreCause mortalityStroke riskTreatment patternsAbsolute riskAssociation guidelinesStroke rateVAScAmerican CollegeLower riskPatientsRemote monitoring of implantable cardiac devices
Ganeshan R, Enriquez AD, Freeman JV. Remote monitoring of implantable cardiac devices. Current Opinion In Cardiology 2018, 33: 20-30. PMID: 29059076, DOI: 10.1097/hco.0000000000000471.Peer-Reviewed Original ResearchConceptsCardiac implantable electronic devicesPatient outcomesHealth resource utilizationRemote monitoring transmissionsRate of hospitalizationNew practice settingsImplantable cardiac devicesImplantable electronic devicesTreatment guidelinesAtrial fibrillationClinical eventsEmergency departmentPhysician carePatient experienceComprehensive followDose relationshipSuperior outcomesPractice settingsCardiac devicesEarly detectionRecent evidenceCareAppropriate useOutcomesPatients